Abstract

The subclassification of incidental prostatic carcinoma into the categories T1a and T1b is of major prognostic and therapeutic relevance. In this paper an attempt was made to find out which properties mainly predispose to these two tumor categories, and whether it is possible to predict the category from a battery of clinical and histopathological variables using newer methods of multivariate data analysis. The incidental prostatic carcinomas of the decade 1990–99 diagnosed at our department were reexamined. Besides acquisition of routine clinical and pathological data, the tumours were scored by immunohistochemistry for proliferative activity and p53‐overexpression. Tumour vascularization (angiogenesis) and epithelial texture were investigated by quantitative stereology. Learning vector quantization (LVQ) and support vector machines (SVM) were used for the purpose of prediction of tumour category from a set of 10 input variables (age, Gleason score, preoperative PSA value, immunohistochemical scores for proliferation and p53‐overexpression, 3 stereological parameters of angiogenesis, 2 stereological parameters of epithelial texture). In a stepwise logistic regression analysis with the tumour categories T1a and T1b as dependent variables, only the Gleason score and the volume fraction of epithelial cells proved to be significant as independent predictor variables of the tumour category. Using LVQ and SVM with the information from all 10 input variables, more than 80 of the cases could be correctly predicted as T1a or T1b category with specificity, sensitivity, negative and positive predictive value from 74–92%. Using only the two significant input variables Gleason score and epithelial volume fraction, the accuracy of prediction was not worse. Thus, descriptive and quantitative texture parameters of tumour cells are of major importance for the extent of propagation in the prostate gland in incidental prostatic adenocarcinomas. Classical statistical tools and neuronal approaches led to consistent conclusions.

Highlights

  • Incidental prostatic cancer is prostatic adenocarcinoma discovered by chance

  • The vascular supply and proliferation of prostatic carcinomas have been investigated in various studies on prostatic cancer in advanced tumour stages [28, 46,50,51]

  • In two previous studies capillary vascularization was studied in incidental prostatic carcinomas [47,48]

Read more

Summary

Introduction

Incidental prostatic cancer is prostatic adenocarcinoma discovered by chance. In contrast to the categories pT2–pT4, it is not a pathologically defined tumour stage but includes a heterogeneous population of cancers with different extent of invasion, and is only. Characterized by the mode of its clinical presentation In most cases such tumours are found at the occasion of transurethral resections (TUR) or surgical adenomectomies of the prostate after a diagnosis of benign prostatic hyperplasia (BPH) [2]. T. Mattfeldt et al / Classification of incidental prostatic cancer ics have been applied to this collective is scarce. Mattfeldt et al / Classification of incidental prostatic cancer ics have been applied to this collective is scarce These techniques have rarely been applied in a multivariate approach in order to look for the relative importance of the factors. We attempted to study all cases of incidental prostatic cancer that were diagnosed in our department in one decade (1990–1999) as a retrospective clinical and histopathological investigation. From all cases with incidental carcinomas, the preoperative PSA-value in the serum estimated according to the Hybritech kit (Hybritech Inc; Beckman Coulter Fullerton, CA; see [23]) was evaluated

Histology and immunohistochemistry
Pathology
Logistic regression analysis
Methods of data classification
Support vector machines
Evaluation with the leave-one-out method
Group comparisons
Logistic regression
Classification of cases by LVQ and SVM
Discussion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call